Innovation, Expansion & Community Care. First-ever Fujifilm Dry Chemistry Technology from Japan, now available in our diagnostic lab, Kollam.
🧪 Our commitment to community-first healthcare drives every upgrade, every partnership, and every milestone.
🧪 First-ever Fujifilm Dry Chemistry Technology from Japan, now available in our diagnostic lab, Kollam
Devi Prime Care proudly announced the installation of Fujifilm’s Dry Chemistry Analyzer, a cutting-edge diagnostic system from Japan, now operational at our Super Special Clinical Laboratory on Residency Road, Kollam. This marks a significant leap in regional diagnostic capability — making us the first facility in Kollam to offer dry chemistry testing with international-grade precision.
Hosted by Logic Events, the launch ceremony brought together pathologists, clinicians, lab technicians, and community leaders to witness the unveiling of this transformative technology. The event featured live demonstrations, comparative analysis with conventional wet chemistry systems, and a walkthrough of the lab’s upgraded workflow.
Unlike traditional analyzers, Fujifilm’s Dry Chemistry Technology uses reagent slides instead of liquid reagents, offering:
- Faster turnaround times
- Minimal sample volume requirements
- Enhanced stability and shelf life
- Reduced contamination risk
- Eco-friendly, water-free operation
This upgrade directly benefits patients by enabling same-day reporting, higher accuracy in liver, kidney, and cardiac panels, and better chronic disease monitoring. It also supports emergency diagnostics, where speed and precision are critical.
The lab team, led by senior pathologist Dr. Radhika Menon, emphasized the role of dry chemistry in improving diagnostic consistency across rural and urban patient populations. The system is now integrated with Devi Prime Care’s digital reporting platform, allowing results to be shared via phone 📲 and email within hours of sample collection.
The launch also included a community pledge to promote early screening, preventive diagnostics, and equitable access to lab services. Special discounts were announced for senior citizens, school health programs, and chronic care patients.
As we continue to expand our diagnostic capabilities, this milestone reflects our promise to bring global innovation to local care — with empathy, precision, and purpose.